LATENCY AND REACTIVATION TUBERCULOSIS
LATENCY AND REACTIVATION TUBERCULOSIS
批准号:
6892152
负责人:
Yukari C Manabe
金额:
$54.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-06-01 至 2007-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Mycobacterium tuberculosis is remarkable in its ability to infect the human
host and remain quiescent for many years only to reactivate when host defenses
are suppressed. One-third of the global population is latently infected with
tuberculosis, yet this clinically inactive state when bacilli are often non-
cultivatable is poorly understood and inadequately characterized. Appropriate
animal models that more accurately mimic human diseases are needed to test
vaccine candidates, and to understand the complex relationship between
mycobacteria and host. The currently available animal models in mice and
guinea pigs are characterized by multibacillary disease and are distinguished
by the host response. Mice mount a poor delayed type hypersensitivity response
and develop chronic lung disease, eventually succumbing to a progressive
granulomatous pulmonary disease with high bacillary load. Guinea pigs also
have a multibacillary disease, but are exquisitely susceptible with rapid
hematogenous dissemination and a strong DTH response that results in rapid
lung inflammation, destruction and death. Paucibacillary latent disease can
only be induced with the administration of antibiotics. In contrast, rabbits
are relatively resistant to aerosol infection with M. tuberculosis and mount a
granulomatous response that effectively contains the bacilli. Over the course
of 6-l2 months, all culturable bacilli disappear. In addition, the
histopathologic response is remarkably similar to that of humans pointing to
the rabbit model of tuberculosis as a promising avenue by which to study
stage-specific changes in both host and bacilli.
In this application, we will aerosol infect rabbits and allow the
granulomatous lung lesions to regress to latency. With the use of
immunosuppressive agents such as corticosteroids, iNOS inhibitors, and
specific anti-cytokine antibody, we will reactivate infection. In parallel, we
will refine the in vitro granuloma assay using rabbit white blood cells to
have an in vitro model with which to correlate and compare our in vivo
results. Harvesting serum and rabbit tissue at various stages of infection, we
will characterize the stage-specific host humoral and cell-mediated immune
responses. Understanding the antibody expression profile during latent disease
may lead to important diagnostics in a disease hampered by diagnostics with
low sensitivity and specificity. In addition, we will analyze the
transcriptional bacterial response to various disease stages using microarrays
and RT-PCR with molecular beacons. Finally, we will use a transposon mutant
library to identify clones that are impaired in specific stages of infection.
Appropriate animal models are critical to the successful development of
tuberculosis vaccines, new drugs and better diagnostic tests for tuberculosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PS16-004, Ending the HIV Epidemic through Point-of-Care Technologies (EHPOC): Performance Evaluation of Novel POC HIV Tests in Baltimore
-
批准号:10907395
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2020
-
负责人:Yukari C Manabe
-
依托单位:
HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis.
-
批准号:9061853
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2014
-
负责人:Yukari C Manabe
-
依托单位:
HIV Co-infections in Uganda: TB, Crypotococcus, and Viral Hepatitis.
-
批准号:8710881
-
项目类别:
-
资助金额:$26.82万
-
财政年份:2014
-
负责人:Yukari C Manabe
-
依托单位:
HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis.
-
批准号:9257476
-
项目类别:
-
资助金额:$28.92万
-
财政年份:2014
-
负责人:Yukari C Manabe
-
依托单位:
Supporting RADx Technology Development: Leveraging International Networks and Clinical Context
-
批准号:10542703
-
项目类别:
-
资助金额:$103.26万
-
财政年份:2007
-
负责人:Yukari C Manabe
-
依托单位:
Clin-Trans-Valid-IDI
-
批准号:10441425
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2007
-
负责人:Yukari C Manabe
-
依托单位:
Administrative Core
-
批准号:10714417
-
项目类别:
-
资助金额:$31.46万
-
财政年份:2007
-
负责人:Yukari C Manabe
-
依托单位:
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases
-
批准号:10441420
-
项目类别:
-
资助金额:$149.42万
-
财政年份:2007
-
负责人:Yukari C Manabe
-
依托单位:
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases
-
批准号:10629799
-
项目类别:
-
资助金额:$210.53万
-
财政年份:2007
-
负责人:Yukari C Manabe
-
依托单位:
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases
-
批准号:10159902
-
项目类别:
-
资助金额:$151.53万
-
财政年份:2007
-
负责人:Yukari C Manabe
-
依托单位:
Clin-Trans-Valid-IDI
-
批准号:10159907
-
项目类别:
-
资助金额:$18.35万
-
财政年份:2007
-
负责人:Yukari C Manabe
-
依托单位:
Center for Innovative Diagnostics for Infectious Diseases
-
批准号:10714416
-
项目类别:
-
资助金额:$154.58万
-
财政年份:2007
-
负责人:Yukari C Manabe
-
依托单位:
LATENCY AND REACTIVATION TUBERCULOSIS
-
批准号:7048486
-
项目类别:
-
资助金额:$47.04万
-
财政年份:2002
-
负责人:Yukari C Manabe
-
依托单位:
LATENCY AND REACTIVATION TUBERCULOSIS
-
批准号:6625837
-
项目类别:
-
资助金额:$47.7万
-
财政年份:2002
-
负责人:Yukari C Manabe
-
依托单位:
LATENCY AND REACTIVATION TUBERCULOSIS
-
批准号:6758544
-
项目类别:
-
资助金额:$45.43万
-
财政年份:2002
-
负责人:Yukari C Manabe
-
依托单位:
IRON REGULATION & VIRULENCE--MYCOBACTERIUM TUBERCULOSIS
-
批准号:6372666
-
项目类别:
-
资助金额:$12.57万
-
财政年份:1999
-
负责人:Yukari C Manabe
-
依托单位:
IRON REGULATION & VIRULENCE--MYCOBACTERIUM TUBERCULOSIS
-
批准号:6532617
-
项目类别:
-
资助金额:$12.57万
-
财政年份:1999
-
负责人:Yukari C Manabe
-
依托单位:
IRON REGULATION & VIRULENCE--MYCOBACTERIUM TUBERCULOSIS
-
批准号:6618006
-
项目类别:
-
资助金额:$12.57万
-
财政年份:1999
-
负责人:Yukari C Manabe
-
依托单位:
IRON REGULATION & VIRULENCE--MYCOBACTERIUM TUBERCULOSIS
-
批准号:2898531
-
项目类别:
-
资助金额:$7.99万
-
财政年份:1999
-
负责人:Yukari C Manabe
-
依托单位:
IRON REGULATION & VIRULENCE--MYCOBACTERIUM TUBERCULOSIS
-
批准号:6169600
-
项目类别:
-
资助金额:$11.49万
-
财政年份:1999
-
负责人:Yukari C Manabe
-
依托单位:
海外基金